Moreover, patients with high level of PD-L1 might have higher risk of death (95 % CI, 0.315 - 0.888, P = 0.016, Table 3) in this cohort of 132 recurrent NPC patients. This evidence concerns the gene CD274 and nasopharyngeal carcinoma.